Agency Forms Undergoing Paperwork Reduction Act Review, 4411-4412 [2013-01163]
Download as PDF
<![CDATA[
Federal Register / Vol. 78, No. 14 / Tuesday, January 22, 2013 / Notices
tkelley on DSK3SPTVN1PROD with
Streets NW.) between 9:00 a.m. and 5:00
p.m. on weekdays.
Additionally, commenters may send a
copy of their comments to the OMB
Desk Officer—Shagufta Ahmed —Office
of Information and Regulatory Affairs,
Office of Management and Budget, New
Executive Office Building, Room 10235
725 17th Street NW., Washington, DC
20503 or by fax to (202) 395–6974.
FOR FURTHER INFORMATION CONTACT: A
copy of the PRA OMB submission,
including the proposed reporting form
and instructions, supporting statement,
and other documentation will be placed
into OMB’s public docket files, once
approved. These documents will also be
made available on the Federal Reserve
Board’s public Web site at: https://
www.federalreserve.gov/apps/
reportforms/review.aspx or may be
requested from the agency clearance
officer, whose name appears below.
Federal Reserve Board Clearance
Officer —Cynthia Ayouch—Division of
Research and Statistics, Board of
Governors of the Federal Reserve
System, Washington, DC 20551 (202)
452–3829.
Telecommunications Device for the
Deaf (TDD) users may contact (202)
263–4869, Board of Governors of the
Federal Reserve System, Washington,
DC 20551.
SUPPLEMENTARY INFORMATION:
Request for Comment on Information
Collection Proposals
The following information
collections, which are being handled
under this delegated authority, have
received initial Board approval and are
hereby published for comment. At the
end of the comment period, the
proposed information collections, along
with an analysis of comments and
recommendations received, will be
submitted to the Board for final
approval under OMB delegated
authority. Comments are invited on the
following:
a. Whether the proposed collection of
information is necessary for the proper
performance of the Federal Reserve’s
functions; including whether the
information has practical utility;
b. The accuracy of the Federal
Reserve’s estimate of the burden of the
proposed information collection,
including the validity of the
methodology and assumptions used;
c. Ways to enhance the quality,
utility, and clarity of the information to
be collected;
d. Ways to minimize the burden of
information collection on respondents,
including through the use of automated
collection techniques or other forms of
information technology; and
VerDate Mar<15>2010
18:11 Jan 18, 2013
Jkt 229001
e. Estimates of capital or start up costs
and costs of operation, maintenance,
and purchase of services to provide
information.
Proposal To Approve Under OMB
Delegated Authority the Extension for
Three Years, Without Revision, of the
Following Reports
1. Report title: Notice of Branch
Closure.
Agency form number: FR 4031.
OMB control number: 7100–0264.
Frequency: On occasion.
Reporters: State member banks.
Estimated annual reporting hours:
224 hours.
Estimated average hours per response:
Reporting requirements, 2 hours;
Disclosure requirements, customer
mailing, 0.75 hours and posted notice,
0.25 hours; and Recordkeeping
requirements, 8 hours.
Number of respondents: Reporting
requirements, 72; Disclosure
requirements, customer mailing, 72 and
posted notice, 72; and Recordkeeping
requirements, 1.
General description of report: This
information collection is mandatory
pursuant to Section 42(a)(1) of the
Federal Deposit Insurance Act (FDI Act)
(12 U.S.C. 1831r–l(a)(1)). The Federal
Reserve does not consider individual
respondent data to be confidential.
However, a state member bank may
request confidential treatment pursuant
to exemption b(4) of the Freedom of
Information Act (5 U.S.C.552(b)(4)).
Abstract: The mandatory reporting,
recordkeeping, and disclosure
requirements regarding the closing of
any branch of an insured depository
institution are imposed by section 228
of the FDI Act of 1991. There is no
reporting form associated with the
reporting portion of this information
collection; state member banks notify
the Federal Reserve by letter prior to
closing a branch. The Federal Reserve
uses the information to fulfill its
statutory obligation to supervise state
member banks
2. Report title: Reports Related to
Securities Issued by State Member
Banks as Required by Regulation H.
Agency form number: Reg H–1.
OMB control number: 7100–0091.
Frequency: Annually, Quarterly, and
on occasion.
Reporters: State member banks.
Estimated annual reporting hours:
352 hours.
Estimated average hours per response:
5.17 hours.
Number of respondents: 4.
General description of report: This
information collection is mandatory
pursuant to sections 12(i) and 23(a)(1) of
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
4411
the Securities Exchange Act of 1934 (15
U.S.C. 781(i) and 78w (a)(1)) and
Regulation H (12 CFR 208.36). The
information collected is not given
confidential treatment. However, a state
member bank make request that a report
or document not be disclosed to the
public and be held confidential by the
Federal Reserve, (12 CFR 208.36(d). All
such requests for confidential treatment
will be determined on an ad hoc basis.
Abstract: The Federal Reserve’s
Regulation H requires certain state
member banks to submit information
relating to their securities to the Federal
Reserve on the same forms that bank
holding companies and nonbank
entities use to submit similar
information to the Securities and
Exchange Commission. The information
is primarily used for public disclosure
and is available to the public upon
request.
Board of Governors of the Federal Reserve
System, January 15, 2013.
Robert deV. Frierson,
Secretary of the Board.
[FR Doc. 2013–01072 Filed 1–18–13; 8:45 am]
BILLING CODE 6210–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–13–12RP]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
chapter 35). To request a copy of these
requests, call (404) 639–7570 or send an
email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC 20503 or by fax to (202) 395–5806.
Written comments should be received
within 30 days of this notice.
Proposed Project
Assessment of the Psychosocial
Impact of Newborn Screening for
Congenital Cytomegalovirus (CMV)
Infection—New—National Center for
Immunization and Respiratory Diseases
(NCIRD) and National Center on Birth
Defects and Developmental Disabilities
(NCBDDD), Centers for Disease Control
and Prevention (CDC).
E:\FR\FM\22JAN1.SGM
22JAN1
4412
Federal Register / Vol. 78, No. 14 / Tuesday, January 22, 2013 / Notices
Background and Brief Description
Each year in the United States, more
than 30,000 children are born with
congenital CMV infection.
Approximately 80% develop normally,
while the remaining 20% are born with
or subsequently develop disabilities
such as hearing loss or mental
retardation. A similar number of
children are affected by serious CMVrelated disabilities than by several
better-known childhood conditions,
including Down Syndrome and Spina
Bifida.
The birth prevalence of congenital
CMV infection is several times higher
than the combined birth prevalence of
all metabolic or endocrine disorders in
the core U.S. newborn screening panel.
Because newborn CMV screening is
rarely performed, and because a
definitive diagnosis of congenital CMV
requires access to urine, saliva, or blood
collected soon after birth, most infected
children are never diagnosed. Newborn
CMV screening offers some clear
potential benefits, but few studies have
assessed the potential for harm (e.g.,
increased parental anxiety, ‘‘fragile
child syndrome’’).
CDC is requesting OMB approval for
one year to collect information about
newborn CMV screening. The purpose
of this information collection is to
understand the psychosocial impact of
newborn screening on parents whose
infants underwent CMV screening as
part of a routine infant CMV screening
program in Houston, Texas. The
potential study population includes
approximately 70 CMV-infected
children who were symptomatic at
birth, 100 CMV-infected children who
were asymptomatic at birth (20 of whom
developed sequelae), and 50 controls
that were CMV-uninfected. The goals of
this information collection are to: (1)
Document the positive and negative
psychosocial impacts of newborn CMV
screening on parents and their children;
(2) identify modifiable factors that might
increase positive psychosocial impacts
and decrease negative psychosocial
impacts of newborn CMV screening; (3)
use what is learned about psychosocial
impacts to identify key messages that
parents need relative to newborn CMV
screening and follow-up; and (4) to
learn what challenges are associated
with obtaining a congenital CMV
diagnosis in the absence of CMV
newborn screening.
Much of the potential study
population is unique in that their
children experienced newborn CMV
screening as part of a previous research
study. Universal CMV screening has not
been recommended by medical
associations or state or federal
governments and as a result newborn
CMV screening is not typically
performed. The parents’ experience
with CMV screening and follow-up will
help inform decisions about whether
newborn CMV screening would be good
public health policy. This study
represents the first assessment of the
experiences of parents whose children
were screened for CMV at birth.
Respondents fall into four categories
depending on the past experiences of
their child who was screened for CMV:
• Parent Group 1 (PG1)—Child
screened positive for congenital CMV at
birth, asymptomatic at birth, but did not
develop sequelae
• Parent Group 2 (PG2)—Child
screened positive for congenital CMV at
birth, asymptomatic at birth, but did
subsequently develop sequelae (e.g.,
hearing loss)
• Parent Group 3 (PG3)—Child was
diagnosed with congenital CMV and
had symptoms at birth
• Parent Group 4 (PG4)—Child
screened negative for congenital CMV at
birth
Information will be collected from
PG1 via focus groups, from PG2 and
PG3 via interviews, and from all four
parent groups via a mail survey. The
focus group, interview and survey
respondents will be asked to participate
only once. It is estimated that 71 parents
will participate in either individual
interviews or focus groups and that 230
will participate in the mail survey. The
interviews are planned to take 60
minutes while the focus groups will be
held for 90 minutes. The survey is
estimated to take 10 minutes per
respondent to complete and mail based
on previous administrations reported in
the literature. Reading and responding
to the focus group and interview
recruitment letters is estimated to take
5 minutes each. There is no cost to
respondents other than their time. The
annualized estimated burden hours are
135.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondent
Form name
Parent Group 1 ...............................................
Focus Group Guide ........................................
Focus group recruitment letter .......................
Interviewer guide ............................................
Interview recruitment letter .............................
Survey ............................................................
Parent Groups 2 and 3 ...................................
Parent Groups 1,2,3, and 4 ............................
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2013–01163 Filed 1–18–13; 8:45 am]
[Document Identifier: CMS–10191]
BILLING CODE P
tkelley on DSK3SPTVN1PROD with
Dated: January 14, 2013.
Ron A. Otten,
Director, Office of Scientific Integrity (OSI),
Office of the Associate Director for Science
(OADS), Office of the Director, Centers for
Disease Control and Prevention.
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare & Medicaid
Services
Centers for Medicare &
Medicaid Services, HHS.
AGENCY:
VerDate Mar<15>2010
18:11 Jan 18, 2013
Jkt 229001
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
36
50
35
50
230
Average
burden per
response
(in hours)
Responses
per
respondent
1
1
1
1
1
1.5
5/60
1
5/60
10/60
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare & Medicaid
Services (CMS) is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
E:\FR\FM\22JAN1.SGM
22JAN1
]]>Agencies
[Federal Register Volume 78, Number 14 (Tuesday, January 22, 2013)]
[Notices]
[Pages 4411-4412]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-01163]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-13-12RP]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. chapter 35). To request a copy of these requests, call
(404) 639-7570 or send an email to omb@cdc.gov. Send written comments
to CDC Desk Officer, Office of Management and Budget, Washington, DC
20503 or by fax to (202) 395-5806. Written comments should be received
within 30 days of this notice.
Proposed Project
Assessment of the Psychosocial Impact of Newborn Screening for
Congenital Cytomegalovirus (CMV) Infection--New--National Center for
Immunization and Respiratory Diseases (NCIRD) and National Center on
Birth Defects and Developmental Disabilities (NCBDDD), Centers for
Disease Control and Prevention (CDC).
[[Page 4412]]
Background and Brief Description
Each year in the United States, more than 30,000 children are born
with congenital CMV infection. Approximately 80% develop normally,
while the remaining 20% are born with or subsequently develop
disabilities such as hearing loss or mental retardation. A similar
number of children are affected by serious CMV-related disabilities
than by several better-known childhood conditions, including Down
Syndrome and Spina Bifida.
The birth prevalence of congenital CMV infection is several times
higher than the combined birth prevalence of all metabolic or endocrine
disorders in the core U.S. newborn screening panel. Because newborn CMV
screening is rarely performed, and because a definitive diagnosis of
congenital CMV requires access to urine, saliva, or blood collected
soon after birth, most infected children are never diagnosed. Newborn
CMV screening offers some clear potential benefits, but few studies
have assessed the potential for harm (e.g., increased parental anxiety,
``fragile child syndrome'').
CDC is requesting OMB approval for one year to collect information
about newborn CMV screening. The purpose of this information collection
is to understand the psychosocial impact of newborn screening on
parents whose infants underwent CMV screening as part of a routine
infant CMV screening program in Houston, Texas. The potential study
population includes approximately 70 CMV-infected children who were
symptomatic at birth, 100 CMV-infected children who were asymptomatic
at birth (20 of whom developed sequelae), and 50 controls that were
CMV-uninfected. The goals of this information collection are to: (1)
Document the positive and negative psychosocial impacts of newborn CMV
screening on parents and their children; (2) identify modifiable
factors that might increase positive psychosocial impacts and decrease
negative psychosocial impacts of newborn CMV screening; (3) use what is
learned about psychosocial impacts to identify key messages that
parents need relative to newborn CMV screening and follow-up; and (4)
to learn what challenges are associated with obtaining a congenital CMV
diagnosis in the absence of CMV newborn screening.
Much of the potential study population is unique in that their
children experienced newborn CMV screening as part of a previous
research study. Universal CMV screening has not been recommended by
medical associations or state or federal governments and as a result
newborn CMV screening is not typically performed. The parents'
experience with CMV screening and follow-up will help inform decisions
about whether newborn CMV screening would be good public health policy.
This study represents the first assessment of the experiences of
parents whose children were screened for CMV at birth.
Respondents fall into four categories depending on the past
experiences of their child who was screened for CMV:
Parent Group 1 (PG1)--Child screened positive for
congenital CMV at birth, asymptomatic at birth, but did not develop
sequelae
Parent Group 2 (PG2)--Child screened positive for
congenital CMV at birth, asymptomatic at birth, but did subsequently
develop sequelae (e.g., hearing loss)
Parent Group 3 (PG3)--Child was diagnosed with congenital
CMV and had symptoms at birth
Parent Group 4 (PG4)--Child screened negative for
congenital CMV at birth
Information will be collected from PG1 via focus groups, from PG2
and PG3 via interviews, and from all four parent groups via a mail
survey. The focus group, interview and survey respondents will be asked
to participate only once. It is estimated that 71 parents will
participate in either individual interviews or focus groups and that
230 will participate in the mail survey. The interviews are planned to
take 60 minutes while the focus groups will be held for 90 minutes. The
survey is estimated to take 10 minutes per respondent to complete and
mail based on previous administrations reported in the literature.
Reading and responding to the focus group and interview recruitment
letters is estimated to take 5 minutes each. There is no cost to
respondents other than their time. The annualized estimated burden
hours are 135.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average burden
Type of respondent Form name Number of Responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Parent Group 1........................ Focus Group Guide....... 36 1 1.5
Focus group recruitment 50 1 5/60
letter.
Parent Groups 2 and 3................. Interviewer guide....... 35 1 1
Interview recruitment 50 1 5/60
letter.
Parent Groups 1,2,3, and 4............ Survey.................. 230 1 10/60
----------------------------------------------------------------------------------------------------------------
Dated: January 14, 2013.
Ron A. Otten,
Director, Office of Scientific Integrity (OSI), Office of the Associate
Director for Science (OADS), Office of the Director, Centers for
Disease Control and Prevention.
[FR Doc. 2013-01163 Filed 1-18-13; 8:45 am]
BILLING CODE P
